Insider Buying: Vitalhub (TSE:VHI) Director Purchases C$49,770.00 in Stock

Vitalhub Corp. (TSE:VHI) Director Anthony Pius Shen purchased 7,000 shares of the company’s stock in a transaction on Monday, March 30th. The stock was bought at an average cost of C$7.11 per share, for a total transaction of C$49,770.00. Following the acquisition, the director directly owned 12,470 shares of the company’s stock, valued at C$88,661.70. This represents a 127.97% increase in their position.

Vitalhub Stock Performance

Shares of TSE:VHI opened at C$6.90 on Thursday. The company has a market capitalization of C$436.30 million, a PE ratio of 69.00, a price-to-earnings-growth ratio of 1.18 and a beta of 0.65. The stock has a fifty day moving average of C$7.98 and a 200-day moving average of C$9.21. Vitalhub Corp. has a one year low of C$6.67 and a one year high of C$14.64.

Vitalhub (TSE:VHI) last issued its earnings results on Wednesday, March 18th. The company reported C$0.06 earnings per share (EPS) for the quarter. Vitalhub had a return on equity of 2.75% and a net margin of 5.61%.The business had revenue of C$31.39 million for the quarter. As a group, research analysts forecast that Vitalhub Corp. will post 0.2296467 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on VHI shares. ATB Cormark Capital Markets cut their price objective on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating on the stock in a report on Tuesday, March 10th. Raymond James Financial decreased their target price on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating for the company in a report on Tuesday, March 24th. Royal Bank Of Canada dropped their target price on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating on the stock in a research report on Monday, January 26th. Finally, Scotiabank cut their price target on shares of Vitalhub from C$15.00 to C$12.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of C$13.86.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.